Fact CheckerSign in

NCT05760690Completed

Safety of Endoscopic Thyroidectomy Via Retro-Auricular Single-Site Approach, Transoral Approach and Transareola

Single-center, Retrospective Study of Retro-Auricular Single-Site Endoscopic, Transoral Endoscopic Thyroidectomy Vestibular Approach and Transareola Endoscopic Thyroidectomy in Patients With Early Stage Papillary Thyroid Carcinoma

Source: ClinicalTrials.gov · Last updated 3 Dec 2024

Brief summary (registry, in English)

The goal of this retrospective study is to compare the safety and efficiacy of endoscopic thyroidectomy via retro-auricular single-site approach, transoral endoscopic thyroidectomy vestibular approach and transareola approach.

Status (registry)
Completed
Study type
Interventional
Enrollment
160 (actual)
First submitted
13 Feb 2023
Start date
1 Jan 2015
Primary completion date
1 Dec 2024
Lead sponsor
Sun Yat-sen University
NCT number
NCT05760690

What you commit to

  • Study type: Interventional
  • Participants enrolled: 160
  • From 1 Jan 2015 to the primary completion date, 1 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who have undergone neck surgery or radiotherapy before this trail.

Other

  • Patients who do not accept case data collection for various reasons.
  • The clinical data unfit this study (at the discretion of the investigator).
  • Patients who have uncontrolled hyperthyroidism.

Who the study is looking for

  • Age 18-70 years old, no gender restrictions.
  • Fine-needle aspiration cytology(FNA) confirmed papillary thyroid carcinoma(PTC).
  • Early stage PTC (stage T1N0M0).
  • Preoperative ultrasonography showed unilateral glandular lobe malignant tumor and the largest diameter was not more than 2cm, without cervical lymph node metastasis and extensive metastasis.
  • Patients undergoing thyroid lobectomy and central lymph node dissection.
  • Patients who have signed an approved Informed Consent.

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sun Yat-sen University Cancer Center
Coordinator of this site? Confirm its status
GuangzhouChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.